Unknown

Dataset Information

Mitochondria-Targeted Drugs.


ABSTRACT:

Background

Targeting of drugs to the subcellular compartments represents one of the modern trends in molecular pharmacology. The approach for targeting mitochondria was developed nearly 50 years ago, but only in the last decade has it started to become widely used for delivering drugs. A number of pathologies are associated with mitochondrial dysfunction, including cardiovascular, neurological, inflammatory and metabolic conditions.

Objective

This mini-review aims to highlight the role of mitochondria in pathophysiological conditions and diseases, to classify and summarize our knowledge about targeting mitochondria and to review the most important preclinical and clinical data relating to the antioxidant lipophilic cations MitoQ and SkQ1.

Methods

This is a review of a

SUBMITTER: Zinovkin RA 

PROVIDER: S-EPMC6875871 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature